Walleye Trading’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-13
| Closed | -$1K | – | 5500 |
|
|
2022
Q1 | $1K | Sell |
13
-734
| -98% | -$109K | ﹤0.01% | 5229 |
|
|
2021
Q4 | $151K | Sell |
747
-3,753
| -83% | -$814K | ﹤0.01% | 4122 |
|
|
2021
Q3 | $1.21M | Buy |
+4,500
| New | +$1.08M | ﹤0.01% | 2019 |
|
|
2021
Q1 | – | Sell |
-773
| Closed | -$197K | – | 5135 |
|
|
2020
Q4 | $197K | Buy |
+773
| New | +$200K | ﹤0.01% | 3528 |
|
|
2020
Q3 | – | Sell |
-333
| Closed | -$116K | – | 4448 |
|
|
2020
Q2 | $116K | Sell |
333
-1,014
| -75% | -$316K | ﹤0.01% | 3423 |
|
|
2020
Q1 | $361K | Buy |
1,347
+60
| +5% | +$18.6K | ﹤0.01% | 2137 |
|
|
2019
Q4 | $417K | Sell |
1,287
-160
| -11% | -$46.4K | ﹤0.01% | 2560 |
|
|
2019
Q3 | $395K | Buy |
1,447
+1,134
| +362% | +$416K | ﹤0.01% | 2370 |
|
|
2019
Q2 | $167K | Buy |
313
+6
| +2% | +$3.01K | ﹤0.01% | 3066 |
|
|
2019
Q1 | $155K | Sell |
307
-40
| -12% | -$23.7K | ﹤0.01% | 3209 |
|
|
2018
Q4 | $171K | Sell |
347
-820
| -70% | -$495K | ﹤0.01% | 3526 |
|
|
2018
Q3 | $1.07M | Buy |
1,167
+154
| +15% | +$131K | 0.01% | 2003 |
|
|
2018
Q2 | $742K | Buy |
1,013
+713
| +238% | +$822K | ﹤0.01% | 2426 |
|
|
2018
Q1 | $478K | Sell |
300
-7
| -2% | -$9.02K | ﹤0.01% | 2700 |
|
|
2017
Q4 | $276 | Sell |
307
-200
| -39% | -$118K | ﹤0.01% | 3152 |
|
|
2017
Q3 | $182 | Buy |
507
+267
| +111% | +$83.5K | ﹤0.01% | 3295 |
|
|
2017
Q2 | $72 | Sell |
240
-1,227
| -84% | -$355K | ﹤0.01% | 3715 |
|
|
2017
Q1 | $516 | Buy |
1,467
+14
| +1% | +$3.15K | ﹤0.01% | 2211 |
|
|
2016
Q4 | $268K | Buy |
1,453
+1,233
| +560% | +$251K | ﹤0.01% | 2579 |
|
|
2016
Q3 | $57K | Buy |
220
+140
| +175% | +$36K | ﹤0.01% | 3683 |
|
|
2016
Q2 | $17K | Buy |
+80
| New | +$17.9K | ﹤0.01% | 4642 |
|
|
2016
Q1 | – | Sell |
-873
| Closed | -$221K | – | 5679 |
|
|
2015
Q4 | $221K | Buy |
+873
| New | +$180K | ﹤0.01% | 2617 |
|
|
2015
Q3 | – | Sell |
-33
| Closed | -$6K | – | 5340 |
|
|
2015
Q2 | $6K | Sell |
33
-34
| -51% | -$5.85K | ﹤0.01% | 4453 |
|
|
2015
Q1 | $12K | Buy |
+67
| New | +$13.8K | ﹤0.01% | 3670 |
|
|
2014
Q4 | – | Sell |
-160
| Closed | -$28K | – | 4419 |
|
|
2014
Q3 | $28K | Sell |
160
-413
| -72% | -$79K | ﹤0.01% | 3429 |
|
|
2014
Q2 | $110 | Buy |
573
+546
| +2,022% | +$96.6K | ﹤0.01% | 2407 |
|
|
2014
Q1 | $5 | Buy |
+27
| New | +$5.34K | ﹤0.01% | 3350 |
|
Other funds holding NKTR
DTC
MAM
SCM
Walleye Trading's NKTR Position: Q2 2023 in Review
Walleye Trading sold out of Nektar Therapeutics (NKTR) in Q2 2023, closing a stake of 5,538 shares — an estimated $58.4K sold.
Walleye Trading first reported a position in NKTR in Q2 2014 and held it in 24 quarters. The position peaked at $681K in Q3 2021. 146 funds tracked by Wall St. Rank hold NKTR as of Q2 2023.
- Walleye Trading reported no remaining Nektar Therapeutics position as of Q2 2023 after selling out during the quarter.
- Walleye Trading sold 5,538 Nektar Therapeutics shares in Q2 2023, an estimated $58.4K.
- Walleye Trading first reported a position in Nektar Therapeutics in Q2 2014 and held it in 24 quarters.
- Walleye Trading's Nektar Therapeutics position peaked at $681K in Q3 2021.
- 146 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2023.
Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.